查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1425852

2024 年 STD 诊断全球市场报告

STD Diagnostics Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

性病诊断的市场规模预计在未来几年将显着成长。预计到 2028 年将以 9.8% 的复合年增长率 (CAGR) 增长至 148.2 亿美元。预测期内的预期成长受到多种因素的推动，包括个人化医疗趋势的出现、医疗保健服务的改善、国家健康策略的实施、远端医疗和数位健康解决方案的整合以及性行为感染感染发病率的增加。可能与因素有关。预计在此期间的显着趋势包括即时检测 (POCT) 的进步、家庭检测套组的可用性、多重检测方法的开发、有针对性的营销和推广工作、暴露前预防 (PrEP) 计划的建立，以及发病率的持续上升。

性行为感染(STD) 的流行是推动 STD 诊断市场向前发展的关键驱动力。 STD（透过性接触传播的感染疾病）是一个全球性的健康问题。世界卫生组织估计，到2022年，全球每天都会发生超过100万例性行为感染传染病，每年新增约3.74亿例感染疾病，包括披衣菌感染、淋病、梅毒和滴虫病，我报告我正在这样做。性病发生率的上升凸显了性病诊断在有效分析和测试推动市场成长方面的重要作用。

医疗保健支出的预期成长预计将进一步推动性病诊断市场的成长。医疗保健支出代表特定医疗保健系统或经济体中用于医疗保健服务和相关活动的总金额，是预防性医疗保健的策略性投资。它解决公共卫生优先事项并有助于整体健康和福祉。英国国家统计局的报告显示，2020 年至 2021 年医疗保健支出增加了 9.4%，截至 2023 年 5 月达到 3,672.5 亿美元（2,807 亿英镑）。其中包括药品支出大幅增加，2021年达到518.4亿美元（396亿英镑），医疗保健支出增加一倍多，达到2021年459.3亿美元（396亿英镑）。医疗保健成本的大幅增加正在推动性传染病诊断市场的发展，突显出透过增强诊断能力来解决性传染病的重要性日益增加。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长，2023-2028、2033

第六章市场区隔

  • 全球性病诊断市场，依类型、实际及预测细分，2018-2023、2023-2028、2033
  • 披衣菌感染测试
  • 梅毒测试
  • 淋病测试
  • 单纯疱疹病毒检测
  • 人类乳突病毒检测
  • 人类免疫力缺乏病毒检测
  • 下疳测试
  • 其他类型
  • 全球性病诊断市场，依测试地点、实际及预测细分，2018-2023、2023-2028、2033
  • 临床检查
  • 照护现场(PoC) 测试
  • 全球性病诊断市场，依最终用户细分，实际与预测，2018-2023、2023-2028、2033
  • 医院和诊所
  • 诊断中心
  • 居家照护

第 7 章 区域与国家分析

  • 全球性病诊断市场，按地区、实际和预测，2018-2023、2023-2028、2033
  • 全球性病诊断市场，依国家、实际及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 性病诊断市场竞争形势
  • 性病诊断市场公司概况
    • Siemens AG
    • Abbott Laboratories
    • Qiagen Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG

第31章竞争基准化分析

第 32 章竞争对手仪表板

第三十三章 重大併购

第34章 未来前景与可能性分析

第35章附录

简介目录
Product Code: r13083

STD Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on std diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for std diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The std diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Chlamydia Testing; Syphilis Testing; Gonorrhea Testing; Herpes Simplex Virus Testing; Human Papilloma Virus Testing; Human Immunodeficiency Virus Testing; Chancroid Testing; Other Types
  • 2) By Location Of Testing: Laboratory Testing; Point Of Care (PoC) Testing
  • 3) By End-User: Hospitals And Clinics; Diagnostic Centers; Homecare
  • Companies Mentioned: Siemens AG; Abbott Laboratories; Qiagen Inc.; Danaher Corporation; F. Hoffmann-La Roche AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Sexually Transmitted Diseases (STDs) diagnostics encompass the examination and identification of infectious conditions transmitted through sexual contact. These diagnostic procedures are essential in determining the presence of STDs within an individual.

The primary categories of STD diagnostics include chlamydia, syphilis, gonorrhea, herpes simplex virus, human papillomavirus, human immunodeficiency virus, chancroid, and other tests performed in laboratory and point-of-care settings. Chlamydia testing involves a urine sample analysis to detect infection. This specific test is employed for identifying chlamydia infections, a common bacterial sexually transmitted infection (STI) transmitted through various forms of sexual contact or genital exposure. These STD diagnostic procedures find application in hospitals, clinics, diagnostic centers, and homecare settings.

The STD diagnostics market research report is one of a series of new reports from The Business Research Company that provides STD diagnostics market statistics, including STD diagnostics industry global market size, regional shares, competitors with a STD diagnostics market share, detailed STD diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the STD diagnostics industry. This STD diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The std diagnostics market size has grown rapidly in recent years. It will grow from $9.25 billion in 2023 to $10.19 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The expansion observed during the historical period can be credited to several factors, including epidemiological patterns, advancements in healthcare infrastructure, progress in pharmaceuticals, implementation of sexual education initiatives, and demographic changes.

The std diagnostics market size is expected to see strong growth in the next few years. It will grow to $14.82 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. During the forecast period, the anticipated growth can be linked to various factors such as the emergence of personalized medicine trends, enhancements in healthcare access, the implementation of population health strategies, the integration of telemedicine and digital health solutions, and the increasing incidence of STDs. Notable trends expected in this period encompass advancements in point-of-care testing (POCT), the availability of home testing kits, the development of multiplex testing methods, targeted marketing and outreach initiatives, the establishment of pre-exposure prophylaxis (PrEP) programs, and the continual rise in incidence rates.

The escalating prevalence of sexually transmitted diseases (STDs) is a significant driver propelling the STD diagnostics market forward. STDs, infectious diseases transmitted through sexual contact, have become a global health concern. In 2022, the World Health Organization reported that over 1 million sexually transmitted infections are acquired daily worldwide, with approximately 374 million new infections annually, including chlamydia, gonorrhea, syphilis, and trichomoniasis. The rising incidence of STDs underscores the critical role of STD diagnostics in efficient analysis and testing, driving the market's growth.

The anticipated increase in healthcare expenditure is expected to further fuel the growth of the STD diagnostics market. Healthcare expenditure, representing the total amount spent on healthcare services and related activities within a specific healthcare system or economy, is a strategic investment in preventive healthcare. It addresses public health priorities and contributes to overall health and well-being. As of May 2023, a report from the Office for National Statistics in the UK revealed a notable 9.4% increase in healthcare spending between 2020 and 2021, reaching $367.25 billion (£280.7 billion). This included a substantial increase in pharmaceutical expenditure, reaching $51.84 billion (£39.6 billion), and more than doubling spending on preventive care, reaching $45.93 billion (£35.1 billion) in 2021. The significant rise in healthcare expenditures emphasizes the growing importance of addressing STDs through enhanced diagnostic capabilities, thereby driving the STD diagnostics market.

A key trend in the STD diagnostics market is the advancement in diagnostic techniques and facilities. Major players are continually upgrading testing facilities to provide more accurate and rapid diagnoses of sexually transmitted diseases. In May 2022, BD (Becton, Dickinson, and Company), a US-based medical technology company, introduced the BD CORTM MX/PX System, a fully automated, high-throughput infectious disease molecular diagnostics platform. This platform streamlines and automates the molecular laboratory workflow, offering improved efficiency from sample processing to diagnostic test results. The platform's first available test is the BD CTGCTV2 molecular assay, capable of identifying the three most common non-viral sexually transmitted infections such as Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV). This technological advancement aligns with the broader trend of enhancing diagnostic capabilities within the STD diagnostics market.

Major players in the STD diagnostics market are actively engaged in the development of innovative products to address unmet medical needs and enhance diagnostic capabilities. One such example is the focus on real-time PCR kits, which are collections of reagents utilized for real-time polymerase chain reaction (qPCR), a sensitive and widely used technique for detecting and quantifying specific nucleic acid sequences. In March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based research and development company, introduced the Mycoplasma Hominis Real Time PCR Kit and the Treponema Pallidum Real Time PCR Kit. These kits are specifically designed for the detection of Mycoplasma hominis and Treponema pallidum. Noteworthy features of these kits include high sensitivity and specificity, ease of use, rapid turnaround time, and the ability to detect multiple pathogens in a single test. This innovation contributes to the advancement of diagnostic capabilities in the field of STD diagnostics, providing healthcare professionals with more effective tools for detection and quantification.

In December 2021, Quest Diagnostics, a prominent US-based medical laboratory company, made a strategic move by acquiring Labtech Diagnostics for an undisclosed amount. This acquisition allowed Quest Diagnostics to expand its access to diagnostics innovation and enhance diagnostic services for consumers in South Carolina and the southeast. Labtech Diagnostics, the acquired company, specializes in clinical laboratories and provides diagnostic services for STDs and other infectious diseases. This strategic acquisition aligns with the broader industry trend of major companies actively seeking to broaden their offerings and enhance their diagnostic capabilities within the STD diagnostics market.

Major companies operating in the std diagnostics market report are Siemens AG, Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., Lybrate Inc., NOWDiagnostics Inc., Alere Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMerieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, InDevR Inc., Inflammatix Inc., Karius Inc., Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

North America was the largest region in the STD diagnostics market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the std diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the std diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The STD diagnostics market consists of revenues earned by entities by providing STD diagnostics tests such as cultural/isolated tests of organisms, molecular tests, and immunology assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The STD diagnostics market also includes sales of thermal cyclers, PCR, lateral flow readers - immuno chromatographic assays, flow cytometers, differential light scattering machines, absorbance microplate readers, phone chips, and rapid diagnostic kits which are used in providing STD diagnostic services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. STD Diagnostics Market Characteristics

3. STD Diagnostics Market Trends And Strategies

4. STD Diagnostics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global STD Diagnostics Market Size and Growth

  • 5.1. Global STD Diagnostics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global STD Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global STD Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. STD Diagnostics Market Segmentation

  • 6.1. Global STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Chlamydia Testing
  • Syphilis Testing
  • Gonorrhea Testing
  • Herpes Simplex Virus Testing
  • Human Papilloma Virus Testing
  • Human Immunodeficiency Virus Testing
  • Chancroid Testing
  • Other Types
  • 6.2. Global STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Laboratory Testing
  • Point Of Care (PoC) Testing
  • 6.3. Global STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Centers
  • Homecare

7. STD Diagnostics Market Regional And Country Analysis

  • 7.1. Global STD Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global STD Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific STD Diagnostics Market

  • 8.1. Asia-Pacific STD Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China STD Diagnostics Market

  • 9.1. China STD Diagnostics Market Overview
  • 9.2. China STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India STD Diagnostics Market

  • 10.1. India STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan STD Diagnostics Market

  • 11.1. Japan STD Diagnostics Market Overview
  • 11.2. Japan STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia STD Diagnostics Market

  • 12.1. Australia STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia STD Diagnostics Market

  • 13.1. Indonesia STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea STD Diagnostics Market

  • 14.1. South Korea STD Diagnostics Market Overview
  • 14.2. South Korea STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe STD Diagnostics Market

  • 15.1. Western Europe STD Diagnostics Market Overview
  • 15.2. Western Europe STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK STD Diagnostics Market

  • 16.1. UK STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany STD Diagnostics Market

  • 17.1. Germany STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France STD Diagnostics Market

  • 18.1. France STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy STD Diagnostics Market

  • 19.1. Italy STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain STD Diagnostics Market

  • 20.1. Spain STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe STD Diagnostics Market

  • 21.1. Eastern Europe STD Diagnostics Market Overview
  • 21.2. Eastern Europe STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia STD Diagnostics Market

  • 22.1. Russia STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America STD Diagnostics Market

  • 23.1. North America STD Diagnostics Market Overview
  • 23.2. North America STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA STD Diagnostics Market

  • 24.1. USA STD Diagnostics Market Overview
  • 24.2. USA STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada STD Diagnostics Market

  • 25.1. Canada STD Diagnostics Market Overview
  • 25.2. Canada STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America STD Diagnostics Market

  • 26.1. South America STD Diagnostics Market Overview
  • 26.2. South America STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil STD Diagnostics Market

  • 27.1. Brazil STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East STD Diagnostics Market

  • 28.1. Middle East STD Diagnostics Market Overview
  • 28.2. Middle East STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa STD Diagnostics Market

  • 29.1. Africa STD Diagnostics Market Overview
  • 29.2. Africa STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa STD Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. STD Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. STD Diagnostics Market Competitive Landscape
  • 30.2. STD Diagnostics Market Company Profiles
    • 30.2.1. Siemens AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Qiagen Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Danaher Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. F. Hoffmann-La Roche AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global STD Diagnostics Market Competitive Benchmarking

32. Global STD Diagnostics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The STD Diagnostics Market

34. STD Diagnostics Market Future Outlook and Potential Analysis

  • 34.1 STD Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 STD Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 STD Diagnostics Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer